In the intro of a series of articles, Nasos Kipentzoglou, Analyst at Lightning API provides a round up of the current mechanisms to obtain marketing authorisation in the UK
Nasos Kipentzoglou, Analyst at Lightning API reviews the recent approach that the G-BA has taken in requiring the mandatory collection of real world evidence for Zolgensma®
Following NICE draft guidance rejecting Zynteglo, Eleanor Butler, Consultant at Lightning API explores why the beta thalassaemia treatment is not recommend for routine NHS funding
Nancy Cross, Analyst, and Eleanor Butler, Consultant at Lightning API review the recently published framework and discuss what this means for stakeholders
60 seconds with Nancy Cross, Analyst
The team at Lightning API would like to…
60 seconds with Nasos Kipentzoglou, Analyst
Lightning API attended the virtual ISPOR Europe 2020, here is our round up of the meeting.
60 seconds with Joshua Beddow, Junior Analyst
60 seconds with Alice Best, Platform and Operations Manager
60 seconds with Eleanor Butler, Consultant
This week our colleagues Eleanor Butler and Marina Kousta attended an ISPOR webinar, read their blog.
60 seconds with Marina Kousta, Analyst
60 seconds with Stuart Hurst, Executive Advisor (Launch Excellence)
60 seconds with Andrew Satherley, Joint Managing Director
60 seconds with James Whitehouse, Joint Managing Director
The UK parliament has published contingency legislation to ensure continuity of medicines access and clinical trials in the event of a no deal Brexit.
The Lightning API team is delighted to announce Dr Frances Macdonald is joining the network as an executive advisor for European HTA.
NHS England has published its long-awaited long-term NHS plan, setting out the strategic objectives for the NHS over the next 10 years.